MedTrace Logo

The CAG Bipolar the CAG Bipolar RCT

NCT04229875 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2023-03-16

No results posted yet for this study

Summary

The CAG Bipolar study is a large-scale pragmatic randomized controlled trial aiming to investigate whether specialized and more centralized treatment (into a clinical academic group (CAG)) improves lives and outcomes for patients with bipolar disorder (N= 1000 patients).

Conditions

Interventions

OTHER

CAG Bipolar

See description of CAG Bipolar

Sponsors & Collaborators

  • Maria Faurholt-Jepsen, MD, DMSc

    collaborator UNKNOWN

  • The Mental Health Services in the Capital Region of Denmark

    collaborator UNKNOWN

  • Mental Health Services in the Capital Region, Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-13
Primary Completion
2023-11-13
Completion
2025-01-13

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04229875 on ClinicalTrials.gov